Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-049802
Filing Date
2013-09-09
Accepted
2013-09-09 16:05:49
Documents
9
Period of Report
2013-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v354219_6k.htm 6-K 12902
2 EXHIBIT 1.1 v354219_ex1-1.htm EX-1.1 170774
3 EXHIBIT 99.1 v354219_ex99-1.htm EX-99.1 208239
  Complete submission text file 0001144204-13-049802.txt   3510443

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rosg-20130630.xml EX-101.INS 221854
5 XBRL TAXONOMY EXTENSION SCHEMA rosg-20130630.xsd EX-101.SCH 25454
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rosg-20130630_cal.xml EX-101.CAL 48611
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rosg-20130630_def.xml EX-101.DEF 66046
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rosg-20130630_lab.xml EX-101.LAB 367361
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rosg-20130630_pre.xml EX-101.PRE 160111
Mailing Address 10 PLAUT STREET, SCIENCE PARK POB 4059 REHOVOT L3 76706
Business Address 10 PLAUT STREET, SCIENCE PARK POB 4059 REHOVOT L3 76706 972-73-222-0700
Rosetta Genomics Ltd. (Filer) CIK: 0001362959 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-33042 | Film No.: 131085712
SIC: 2834 Pharmaceutical Preparations